Related Experiment Video
Updated: Aug 11, 2026
12:03
Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
[Stem cells in hematology and oncology]
Hartmut Goldschmidt1, Gerlinde Egerer, Stefan Fruehauf
1Medizinische Klinik und Poliklinik V, Universität Heidelberg. hartmut_goldschmidt@med.uni-heidelberg.de
Medizinische Klinik (Munich, Germany : 1983)
|March 3, 2004
Summary
Hematopoietic stem cell transplantation has advanced significantly, offering improved outcomes for various cancers. Current methods enhance stem cell mobilization and quantification, leading to faster patient recovery and better prognoses.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Hematopoietic stem cells (HSCs) were initially conceptualized as lymphocyte-like cells.
- The past two decades have seen a rise in autologous and allogeneic HSC transplantation procedures.
- Hematopoietic growth factors facilitate HSC mobilization from bone marrow to peripheral blood.
Purpose:
- To review the advancements and applications of hematopoietic stem cell transplantation.
- To highlight the role of HSC quantification and transplantation in treating hematologic malignancies.
- To discuss the evolving role of reduced-intensity conditioning in allogeneic transplantation.
Summary:
- Flow cytometry enables rapid quantification of HSCs, with a minimum of 2.0 x 10^6 CD34+ cells/kg required for timely hematopoietic reconstitution.
- High-dose therapy followed by autologous stem cell transplantation is standard for relapsed lymphoma and multiple myeloma.
- Allogeneic stem cell transplantation, particularly with myeloablative conditioning, improves prognosis for specific acute myeloid leukemia, myelodysplastic, and myeloproliferative syndromes.
- Reduced conditioning regimens decrease early mortality in allogeneic transplantation.
- Combining myeloablative therapy with autologous and allogeneic stem cell transplantation maximizes tumor reduction and graft-versus-leukemia effects while minimizing toxicity.
Impact:
- Hematopoietic stem cell transplantation is a critical therapeutic strategy for hematologic malignancies.
- Advancements in HSC mobilization, quantification, and transplantation protocols are improving patient outcomes.
- Future research and clinical studies are essential to further refine and expand the application of stem cell transplantation.
Related Concept Videos
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:34Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...